Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NVCT | US
0.17
2.50%
Healthcare
Biotechnology
30/06/2024
30/08/2024
6.96
6.87
6.96
6.76
Nuvectis Pharma Inc. a biopharmaceutical company focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company develops NXP800 a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900 a small molecule drug candidate that inhibits the Proto-oncogene c-Src and YES1 kinases. It has license agreement with the CRT Pioneer Fund for the NXP800 and any of related derivatives; and the University of Edinburgh for the NXP900 and any of associated derivatives. The company was formerly known as Centry Pharma Inc. and changed its name to Nuvectis Pharma Inc. in July 2021. Nuvectis Pharma Inc. was incorporated in 2020 and is based in Fort Lee New Jersey.
View LessLow Market Beta (-0.4 to 0.8)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
58.0%1 month
71.9%3 months
63.4%6 months
81.1%-
-
10.36
-
-
-7.38
-
-
-
129.82M
129.82M
-
-
-
-
-128.44
18.01
9.51
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.49
Range1M
1.75
Range3M
1.75
Rel. volume
0.61
Price X volume
440.94K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
LogicBio Therapeutics Inc | LOGC | Biotechnology | 5.4 | 141.88M | -0.55% | n/a | 0.00% |
Medicenna Therapeutics Corp | MDNAF | Biotechnology | 1.85 | 141.40M | 17.83% | n/a | 0.00% |
Vigil Neuroscience Inc. Common Stock | VIGL | Biotechnology | 3.48 | 137.97M | 1.16% | n/a | 15.72% |
QSI | QSI | Biotechnology | 0.9468 | 134.79M | -2.44% | n/a | 0.71% |
Kodiak Sciences Inc | KOD | Biotechnology | 2.51 | 132.06M | 1.21% | n/a | 81.94% |
INmune Bio Inc | INMB | Biotechnology | 6.62 | 130.96M | -3.50% | n/a | 14.65% |
Inventiva S.A | IVA | Biotechnology | 2.265 | 125.13M | -5.23% | n/a | -115.26% |
Adagene Inc. | ADAG | Biotechnology | 2.8 | 123.96M | -3.45% | n/a | 36.74% |
Repare Therapeutics Inc | RPTX | Biotechnology | 2.91 | 123.52M | -3.32% | n/a | 1.07% |
Puma Biotechnology Inc | PBYI | Biotechnology | 2.5 | 122.62M | 2.04% | 13.16 | 203.23% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Saga Communications Inc | SGA | Broadcasting - Radio | 14.72 | 92.17M | -2.06% | 14.72 | 7.10% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.38 | 76.89M | 5.34% | n/a | 268.43% |
Emmis Communications Corporation | EMMS | Broadcasting - Radio | 4.7 | 57.98M | -1.05% | n/a | 54.59% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.34 | 28.51M | 13.04% | n/a | 16.03% |
ILAG | ILAG | Building Products & Equipment | 1.25 | 22.57M | 6.84% | n/a | 5.48% |
Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 0.6131 | 18.67M | -4.20% | n/a | 204.46% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2495 | 3.93M | 5.94% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.391 | 3.72M | -6.28% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.45 | 3.70M | 13.28% | n/a | 9.62% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -7.38 | 0.97 | Cheaper |
Ent. to Revenue | - | 3,681.29 | - |
PE Ratio | - | 39.83 | - |
Price to Book | 10.36 | 14.54 | Cheaper |
Dividend Yield | - | 2.19 | - |
Std. Deviation (3M) | 63.43 | 76.13 | Par |
Debt to Equity | - | -2.05 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 129.82M | 4.04B | Emerging |